rasagiline has been researched along with Aging in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amit, T; Badinter, F; Bar-Am, O; Weinreb, O; Youdim, MB | 1 |
| Cohen, S; Dror, V; Eliash, S; Rehavi, M | 1 |
| Chen, JJ; Fernandez, HH | 1 |
| Cohen, S; Levy, R; Speiser, Z | 1 |
| Maruyama, W; Naoi, M | 1 |
| Carrillo, MC; Ivy, GO; Kanai, S; Kitani, K; Maruyama, W; Minami, C; Yamamoto, T | 1 |
2 review(s) available for rasagiline and Aging
| Article | Year |
|---|---|
Community and long-term care management of Parkinson's disease in the elderly: focus on monoamine oxidase type B inhibitors.
Topics: Aged; Aging; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Homes for the Aged; Humans; Indans; Levodopa; Monoamine Oxidase Inhibitors; Nursing Homes; Parkinson Disease; Selegiline | 2007 |
Do antioxidant strategies work against aging and age-associated disorders? Propargylamines: a possible antioxidant strategy.
Topics: Aging; Alkynes; Animals; Antioxidants; Brain; Brain Chemistry; Catalase; Corpus Striatum; Cricetinae; Dogs; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Induction; Female; Free Radicals; Heart; Humans; Indans; Kidney; Longevity; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Neuroprotective Agents; Organ Specificity; Rats; Rats, Inbred F344; Selegiline; Superoxide Dismutase | 2001 |
4 other study(ies) available for rasagiline and Aging
| Article | Year |
|---|---|
Effect of long-term treatment with rasagiline on cognitive deficits and related molecular cascades in aged mice.
Topics: Aging; Animals; Catecholamines; Cognition Disorders; Corpus Striatum; Disease Models, Animal; Exploratory Behavior; Gene Expression Regulation; Indans; Longitudinal Studies; Male; Maze Learning; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Neuroprotective Agents; Receptors, Dopamine D1; Receptors, Dopamine D2; Signal Transduction; Swimming | 2015 |
Neuroprotection by rasagiline in thiamine deficient rats.
Topics: Aging; Analysis of Variance; Animals; Behavior, Animal; Brain; Disease Models, Animal; Indans; Kaplan-Meier Estimate; Male; Maze Learning; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nerve Degeneration; Neuroprotective Agents; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Selegiline; Thiamine Deficiency | 2009 |
Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders.
Topics: Aging; alpha-Methyltyrosine; Animals; Avoidance Learning; Catalepsy; Cognition; Cognition Disorders; Haloperidol; Hypokinesia; Hypoxia; Indans; Male; Memory; Mice; Mice, Inbred ICR; Monoamine Oxidase Inhibitors; Motor Activity; Rats; Rats, Wistar | 1998 |
Neuroprotection by (-)-deprenyl and related compounds.
Topics: Aging; Amphetamines; Animals; Antioxidants; Apoptosis; Cattle; DNA Damage; DNA, Neoplasm; Indans; Monoamine Oxidase Inhibitors; Neuroblastoma; Neuroprotective Agents; Nitrates; Oxidants; Parkinson Disease; Selegiline; Tumor Cells, Cultured | 1999 |